Literature DB >> 10601123

Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats.

H Honda1, T Unemoto, H Kogo.   

Abstract

The tension in isolated ring preparations of the thoracic aortae from Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) was measured isometrically to study the differences in testosterone-induced relaxation between WKY and SHR aortic rings. Testosterone (9 to 300 micromol/L) induced a concentration-dependent relaxation in both WKY and SHR aortic rings, and the relaxation induced by testosterone was greater in SHR than WKY. The relaxation induced by testosterone was significantly reduced by denudation of endothelium in SHR but not WKY. Indomethacin, an inhibitor of cyclooxygenase, and N(G)-nitro-L-arginine, an inhibitor of nitric oxide (NO) synthase, showed little influence on the relaxation induced by testosterone in both WKY and SHR aortic rings. Glibenclamide, a selective inhibitor of ATP-sensitive potassium channels, significantly reduced the relaxation induced by testosterone in both WKY and SHR aortic rings, although the extent of reduction was greater in WKY than SHR. On the other hand, 4-aminopyridine, a selective inhibitor of voltage-dependent potassium channels, and tetraethylammonium, an inhibitor of calcium-activated potassium channels, significantly reduced the relaxation induced by testosterone in SHR but not WKY. These results suggest that the mechanisms of testosterone-induced vasorelaxation in both WKY and SHR involve, in part, ATP-sensitive potassium channels in the thoracic aortae and that in SHR aortic rings, testosterone may release endothelium-derived substances that may cause hyperpolarization of the cells by a mechanism that involves potassium channels. Moreover, the data show differences between WKY and SHR in the function of ATP-sensitive, voltage-dependent, and calcium-activated potassium channels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601123     DOI: 10.1161/01.hyp.34.6.1232

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

1.  The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs.

Authors:  C Molinari; A Battaglia; E Grossini; D A S G Mary; C Vassanelli; G Vacca
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

Review 2.  The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?

Authors:  Richard D Jones; Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 3.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

Review 4.  Effects of antihypertensive therapy on sexual activity in hypertensive men.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 5.  Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites.

Authors:  Mercedes Perusquía; John N Stallone
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-12       Impact factor: 4.733

Review 6.  Testosterone and coronary vascular tone: implications in coronary artery disease.

Authors:  F L Wynne; R A Khalil
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

7.  Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition.

Authors:  E Alvarez; E Cairrão; M Morgado; C Morais; I Verde
Journal:  Adv Pharmacol Sci       Date:  2010-03-30

8.  Potassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery.

Authors:  Elisa Cairrão; Ezequiel Alvarez; António José Santos-Silva; Ignacio Verde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-20       Impact factor: 3.000

9.  Androgenicity and venous endothelial function in post-menopausal women.

Authors:  M A Maturana; M C Rubira; F Consolim-Colombo; M C Irigoyen; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

10.  Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.

Authors:  Reagan L Ross; Michelle R Serock; Raouf A Khalil
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.